Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients
Authors:
- Marcello GovoniMGMarcello Govoni
- Stefano BombardieriSBStefano Bombardieri
- Alessandra BortoluzziABAlessandra Bortoluzzi
- Luisa CaniattiLCLuisa Caniatti
- Cinzia CasuCCCinzia Casu
- Fabrizio ContiFCFabrizio Conti
- Salvatore De VitaSVSalvatore De Vita
- Andrea DoriaADAndrea Doria
- Ilaria FarinaIFIlaria Farina
- Gianfranco FerraccioliGFGianfranco Ferraccioli
- Elisa GremeseEGElisa Gremese
- Elisa MansuttiEMElisa Mansutti
Open Access
- 10 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 51 (1) , 157-168
Abstract
Objective. To analyse risk factors and comorbidities potentially associated with CNS involvement in a large cohort of Italian patients affected by SLE. Methods. A number of generic (not strictly SLE related) and specific (disease related) risk factors to which all patients have been exposed in the span of 5 years before the first neuropsychiatric (NP) event or before the last available observation were checked for and their distribution was analysed in 959 SLE patients with and without NP involvement; all the first NP events that occurred in a time frame of 10 years were recorded and categorized as SLE related or SLE unrelated. Results. Three hundred and twenty-six SLE patients with and 633 SLE patients without NP manifestations were included in the study. A total of 469 NP events were recorded. Headache (26.1%), cerebrovascular events (22.7%), mood disorders (8.9%), seizures (14.4%) and cognitive dysfunctions (9.5%) were the most frequent SLE-related NP events. More risk factors [mean 4.52 (2.44) vs 3.73 (2.01); P < 0.0001] were observed in patients with than without NP involvement. Overall, aPLs, LA and APS were factors more strongly associated with NP involvement. Conclusions. In SLE, NP involvement and aPLs were confirmed as closely related. Furthermore, other modifiable generic risk factors, such as hypertension, carotid vasculopathy and dyslipidaemia, appeared to be related to the occurrence of cerebral vascular accident (CVA) and cognitive dysfunctions, suggesting the need for a more intensive preventive strategy to optimize the management of NP lupus.Keywords
This publication has 40 references indexed in Scilit:
- The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practiceLupus, 2011
- Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort studyArthritis & Rheumatism, 2007
- Mortality related to cerebrovascular disease in systemic lupus erythematosusLupus, 2006
- Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population‐based evaluationArthritis & Rheumatism, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis & Rheumatism, 1999
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- A multicenter study of outcome in systemic lupus erythematosus.Arthritis & Rheumatism, 1982